Asia Insurance Post
  • Home
  • Articles
  • Blog
  • Data
  • Facts
  • Editorial
  • Interviews
Select Page

Covaxin safe, shows 77.8 per cent efficacy against symptomatic COVID-19: Lancet study

by Agencies | Nov 12, 2021 | Health, Indian News, Non-Life, Pandemic

Covaxin, an inactivated whole virus vaccine developed by Hyderabad-based Bharat Biotech, recently received emergency use approval from the World Health Organization (WHO) for people aged 18 and above. Two doses of Covaxin, India’s indigenous COVID-19 vaccine,...
Next Entries »

Recent Posts

  • US calls on G7, EU to impose tariffs on China, India over Russian oil purchases
  • PM Modi to launch ‘Swasth Nari, Sashakt Parivar Abhiyaan’ on Sep 17
  • Tobacco kills 1.35 million Indians every year, but quit rates remain very low despite widespread awareness
  • BIS working on battery swapping in e-mobility sector, says Director General Tiwari
  • Amid rising HNIs, wealth management firms in India to grow 20%+ over next 3 years: Jefferies

Categories

  • Articles
  • Banking & Bancassurance
  • Blog
  • Breaking News!
  • Briefs
  • Climate, Environment, Renewable Energy
  • Data
  • Disaster & Management
  • Eco/Invest/Demography
  • Editorial
  • Events
  • Facts
  • Features
  • Health
  • Indian News
  • Intermediaries
  • International News
  • Interviews
  • Life
  • Main Menu
  • Non-Life
  • Pandemic
  • Pension & Social Security
  • Policy
  • Regulation
  • Reinsurance
  • Risk Management
  • Simple
  • Technology
  • Trends, Facts
  • Uncategorized
  • Wealth Management/ Philanthropy
  • Workplace/Employee Benefits
  • Home
  • Articles
  • Blog
  • Data
  • Facts
  • Editorial
  • Interviews
  • Eco/Invest/Demography
  • Indian News
  • International News
  • Health
  • Non-Life
  • Pandemic
  • Technology
  • Risk Management
  • Reinsurance
  • Banking & Bancassurance
  • Wealth Management/ Philanthropy